Although treatment with ACA did not inhibit B cell activation, as assessed by CD79α expression, our results show that ACA is effective at reducing populations of CD4+ Th cells and CD8+ cytotoxic T cells in the lungs of mice with OVA-induced asthma. Here, CD79A is linked to asthma.